株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

オピオイド薬市場の世界市場の将来予測

Global Opioids Drug Market Forecast 2019-2027

発行 Inkwood Research 商品コード 750061
出版日 ページ情報 英文 166 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
オピオイド薬市場の世界市場の将来予測 Global Opioids Drug Market Forecast 2019-2027
出版日: 2018年11月29日 ページ情報: 英文 166 Pages
概要

当レポートでは、世界のオピオイド薬市場の将来展望について分析し、製品の概要や市場の構造、主な市場促進・抑制要因、全体的な市場規模の動向見通し (今後9年間分)、製品別・用途別および地域別の詳細動向、市場競争環境、主要企業のプロファイルなどを調査しております。

第1章 分析範囲

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場のダイナミクス

  • 市場の範囲と定義
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第5章 製品別の市場

  • ブプレノルフィン
  • フェンタニル
  • ヒドロコドン
  • モルヒネ
  • オキシコドン
  • トラマドール
  • その他の製品

第6章 用途別の市場

  • 疼痛緩和
    • がん疼痛
    • 術後疼痛管理
    • 腰痛
    • 整形外科
    • 神経障害
    • 線維筋痛症
  • 麻酔
  • 咳止め
  • 下痢止め
  • 依存症治療

第7章 主要指標

  • ポーターのファイブフォース分析
  • 規制体制
  • パイプライン製品の分析
  • 近年の業界の主な動き:オピオイド薬市場
  • 技術進歩
  • 市場機会マトリックス

第8章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (ドイツ、フランス、英国、スペイン、イタリアなど)
  • アジア太平洋地域 (日本、中国、インド、オーストラリア、韓国など)
  • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第9章 競争環境

  • 市場ポジショニング分析
  • 企業プロファイル
    • ACURA PHARMACEUTICALS, INC.
    • ALLERGAN PLC
    • BIODELIVERY SCIENCES INTERNATIONAL, INC.
    • CIPHER PHARMACEUTICALS INC.
    • COLLEGIUM PHARMACEUTICAL, INC.
    • 第一三共
    • EGALET CORP.
    • HIKMA PHARMACEUTICALS PLC
    • INDIVIOR INC.
    • INSYS THERAPEUTICS, INC.
    • JANSSEN PHARMACEUTICALS, INC.
    • JOHNSON & JOHNSON
    • LANNETT CO. INC.
    • LUPIN LTD.
    • MYLAN NV
    • PFIZER INC.
    • PURDUE PHARMA LP
    • SANOFI-AVENTIS S.A.
    • SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
    • TEVA PHARMACEUTICAL INDUSTRIES LTD.
図表

LIST OF TABLES

  • TABLE 1: GLOBAL OPIOIDS DRUG MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2: ANESTHETIC EFFECTS OF DRUGS AT DIFFERENT OPIOID RECEPTORS
  • TABLE 3: FDA APPROVED OPIOIDS WITH ADF LABELLING
  • TABLE 4: NUMBER OF LAWSUITS CASES SETTLED BY OPIOIDS MANUFACTURING COMPANIES AND PHARMACIES 2015-2027
  • TABLE 5: GLOBAL OPIOIDS DRUGS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
  • TABLE 6: GLOBAL BUPRENORPHINE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 7: GLOBAL FENTANYL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 8: GLOBAL HYDROCODONE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 9: GLOBAL MORPHINE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 10: GLOBAL OXYCODONE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 11: GLOBAL TRAMADOL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 12: GLOBAL OTHER PRODUCTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 13: GLOBAL OPIOIDS DRUGS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 14: GLOBAL OPIOIDS DRUGS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 15: GLOBAL PAIN RELIEF MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 16: GLOBAL PAIN RELIEF MARKET BY TYPES 2019-2027 ($ MILLION)
  • TABLE 17: GLOBAL CANCER PAIN MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 18: GLOBAL POSTOPERATIVE PAIN MANAGEMENT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 19: GLOBAL LOW BACK PAIN MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 20: GLOBAL ORTHOPEDIC MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 21: GLOBAL NEUROPATHIC MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 22: GLOBAL FIBROMYALGIA MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 23: GLOBAL ANESTHESIA MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 24: GLOBAL COUGH SUPPRESSION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 25: GLOBAL DIARRHEA SUPPRESSION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 26: GLOBAL DEADDICTION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 27: LIST OF ER/LA OPIOID BRANDED DRUGS 2017
  • TABLE 28: LISTS OF ER/LA OPIOID GENERIC DRUGS 2017
  • TABLE 29: CDC GUIDELINES ON PRESCRIBING OPIOIDS
  • TABLE 30: PIPELINE ANALYSES OF OPIOID DRUGS
  • TABLE 31: GLOBAL OPIOIDS DRUGS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 32: NORTH AMERICA OPIOIDS DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 33: NUMBER OF OPIOIDS PRESCRIPTIONS IN CANADA 2015-2016 (MILLIONS)
  • TABLE 34: EUROPE OPIOIDS DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 35: ASIA PACIFIC GERD DRUGS AND DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 36: REST OF THE WORLD OPIOIDS DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL OPIOIDS DRUG MARKET 2019-2027 ($ MILLION)
  • FIGURE 2: NUMBER OF DEATHS IN THE UNITED STATES DUE TO DRUG OVERDOSE 2010-2016
  • FIGURE 3: GLOBAL OPIOIDS DRUGS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
  • FIGURE 4: GLOBAL OPIOIDS DRUGS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 5: PORTER'S FIVE FORCE MODEL
  • FIGURE 6: GLOBAL OPIOIDS DRUGS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 7: THE UNITED STATES OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 8: NUMBER OF OPIOID PRESCRIPTIONS DISPENSED IN THE UNITED STATES 2015-2017 (MILLIONS)
  • FIGURE 9: NUMBER OF DRUG OVERDOSE DEATHS IN THE UNITED STATES 2010-2016
  • FIGURE 10: CANADA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 11: GERMANY OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 12: FRANCE OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 13: THE UNITED KINGDOM OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 14: SPAIN OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 15: ITALY OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 16: REST OF EUROPE OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 17: JAPAN GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
  • FIGURE 18: CHINA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
  • FIGURE 19: INDIA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
  • FIGURE 20: AUSTRALIA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 21: SOUTH KOREA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 22: REST OF ASIA PACIFIC OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 23: LATIN AMERICA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 24: MIDDLE EAST AND AFRICA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)
  • FIGURE 25: OPIOIDS MARKET POSITION ANALYSIS 2017
目次
Product Code: 22680

KEY FINDINGS:

The global opioids drugs market is anticipated to grow at a CAGR of 2.52% between 2019 and 2027. Opioids are narcotic drugs and mostly directed for pain management. Increasing case of road accidents & surgical procedures are the main drivers that are propagating the global market growth for opioids drugs.

MARKET INSIGHTS:

The opioid drugs are commonly used for alleviating the post-operative pains caused by surgical procedures. Opioid drugs are approved by FDA in the United States with ADF labeling and are currently marketed in North America. The market is segmented by products and applications, out of which, the former's oxycodone sub-segment is estimated to hold the highest market share in 2018. Growing demand for palliative care that aims to improve the quality of life for the patient suffering from terminal illness by implementing the use of opioid drugs is further driving the said market's growth. The growing opioid addiction crisis is leading to submission of lawsuits against pharmaceuticals companies who are manufacturing the opioid drugs.

REGIONAL INSIGHTS:

The global market for opioid drugs is geographically segmented into four regions, namely, North America, Asia-Pacific, Europe and countries from the Rest of the World. The North American economy holds the largest share for the market by revenue in the forecast years. The recurrently increasing geriatric population who are prone to irreversible and incurable disorders and chronic diseases are further enhancing the demand for pain management treatments in the market. Investments from local, regional players in the development of abuse-deterrent morphine drug are attributing for a high growth rate of morphine drug in the region.

COMPETITIVE INSIGHTS:

Acura Pharmaceuticals, Inc., Allergan PLC, BioDelivery Sciences International, Inc., Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Daiichi Sankyo, Inc., Egalet Corp., Hikma Pharmaceuticals PLC, Indivior, Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lannett Co. Inc., Lupin Ltd., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A., Sun Pharmaceutical Industries Limited (Sun Pharma) and Teva Pharmaceutical Industries Ltd. are some of the key market players who are dominating the global opioids market.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. OXYCODONE HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCT
    • 3.2.2. ANESTHESIA IS THE MAJORLY USED APPLICATION

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
    • 4.2.2. ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
    • 4.2.3. USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
    • 4.2.4. GROWING OCCURRENCE OF CHRONIC PAIN
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. MISUSE OF OPIOIDS
    • 4.3.2. STRINGENT REGULATORY FRAMEWORK
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. INCREASING USE OF EXTENDED-RELEASE OPIOID FORMULATIONS
    • 4.4.2. WIDE RANGE OF APPLICATIONS OF OPIOIDS IN THE THERAPEUTIC MANAGEMENT
  • 4.5. MARKET CHALLENGES
    • 4.5.1. INCREASING NUMBER OF LAWSUITS CASES AGAINST OPIOIDS MANUFACTURERS
    • 4.5.2. RISING OCCURRENCE OF DEATHS RELATED TO OPIOID OVERDOSE

5. MARKET BY PRODUCTS

  • 5.1. BUPRENORPHINE
  • 5.2. FENTANYL
  • 5.3. HYDROCODONE
  • 5.4. MORPHINE
  • 5.5. OXYCODONE
  • 5.6. TRAMADOL
  • 5.7. OTHER PRODUCTS

6. MARKET BY APPLICATION

  • 6.1. PAIN RELIEF
    • 6.1.1. CANCER PAIN
    • 6.1.2. POSTOPERATIVE PAIN MANAGEMENT
    • 6.1.3. LOW BACK PAIN
    • 6.1.4. ORTHOPEDIC
    • 6.1.5. NEUROPATHIC
    • 6.1.6. FIBROMYALGIA
  • 6.2. ANESTHESIA
  • 6.3. COUGH SUPPRESSION
  • 6.4. DIARRHEA SUPPRESSION
  • 6.5. DEADDICTION

7. KEY ANALYTICS

  • 7.1. PORTER'S FIVE FORCE MODEL
    • 7.1.1. THREAT OF NEW ENTRANTS
    • 7.1.2. THREAT OF SUBSTITUTE
    • 7.1.3. BARGAINING POWER OF SUPPLIERS
    • 7.1.4. BARGAINING POWER OF BUYERS
    • 7.1.5. THREAT OF COMPETITIVE RIVALRY
  • 7.2. REGULATORY FRAMEWORK
  • 7.3. PIPELINE ANALYSIS
  • 7.4. INDUSTRY EVENTS IN OPIOID DRUGS MARKET
  • 7.5. TECHNOLOGIES ADVANCEMENT
  • 7.6. OPPORTUNITY MATRIX

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. THE UNITED STATES
    • 8.1.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. GERMANY
    • 8.2.2. FRANCE
    • 8.2.3. THE UNITED KINGDOM
    • 8.2.4. SPAIN
    • 8.2.5. ITALY
    • 8.2.6. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. JAPAN
    • 8.3.2. CHINA
    • 8.3.3. INDIA
    • 8.3.4. AUSTRALIA
    • 8.3.5. SOUTH KOREA
    • 8.3.6. REST OF ASIA PACIFIC
  • 8.4. REST OF THE WORLD
    • 8.4.1. LATIN AMERICA
    • 8.4.2. MIDDLE EAST AND AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. MARKET POSITION ANALYSIS
  • 9.2. COMPANY PROFILES
    • 9.2.1. ACURA PHARMACEUTICALS, INC.
    • 9.2.2. ALLERGAN PLC
    • 9.2.3. BIODELIVERY SCIENCES INTERNATIONAL, INC.
    • 9.2.4. CIPHER PHARMACEUTICALS INC.
    • 9.2.5. COLLEGIUM PHARMACEUTICAL, INC.
    • 9.2.6. DAIICHI SANKYO, INC.
    • 9.2.7. EGALET CORP.
    • 9.2.8. HIKMA PHARMACEUTICALS PLC
    • 9.2.9. INDIVIOR INC.
    • 9.2.10. INSYS THERAPEUTICS, INC.
    • 9.2.11. JANSSEN PHARMACEUTICALS, INC.
    • 9.2.12. JOHNSON & JOHNSON
    • 9.2.13. LANNETT CO. INC.
    • 9.2.14. LUPIN LTD.
    • 9.2.15. MYLAN NV
    • 9.2.16. PFIZER INC.
    • 9.2.17. PURDUE PHARMA LP
    • 9.2.18. SANOFI-AVENTIS S.A.
    • 9.2.19. SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
    • 9.2.20. TEVA PHARMACEUTICAL INDUSTRIES LTD.
Back to Top